Literature DB >> 9555027

A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions.

T L Sandhya1, W Y Ong, L A Horrocks, A A Farooqui.   

Abstract

The systemic administration of kainate (10 mg/ml) into adult Wistar rats produces seizures and neurodegeneration. We have studied the effect of kainate administration on cPLA2 and COX-2 immunoreactivities after 3 days and 1, 2, 4 and 11 weeks. The cPLA2 immunoreactivity was increased in hippocampal neurons at 1 and 3 days after kainate injection suggesting that PLA2 may be involved in neurodegeneration. Increased cPLA2 and COX-2 immunoreactivities in astrocytes at 1, 2, 4 and 11 weeks after kainate injection indicate an adaptive astrocytic response that may be associated with gliosis. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555027     DOI: 10.1016/s0006-8993(97)01552-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  26 in total

1.  Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.

Authors:  G E Serrano; N Lelutiu; A Rojas; S Cochi; R Shaw; C D Makinson; D Wang; G A FitzGerald; R Dingledine
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

2.  Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide.

Authors:  Thad A Rosenberger; Nelly E Villacreses; Margaret T Weis; Stanley I Rapoport
Journal:  Neurochem Int       Date:  2009-12-22       Impact factor: 3.921

3.  cPLA2 in Epilepsy: Shutting Down the Leaker at Its Source.

Authors:  Christina Gross
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

4.  Simultaneous lipidomic and transcriptomic profiling in mouse brain punches of acute epileptic seizure model compared to controls.

Authors:  Raissa Lerner; Julia M Post; Shane R Ellis; D R Naomi Vos; Ron M A Heeren; Beat Lutz; Laura Bindila
Journal:  J Lipid Res       Date:  2017-12-05       Impact factor: 5.922

Review 5.  Phospholipases A2 in ischemic and toxic brain injury.

Authors:  A Sapirstein; J V Bonventre
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

Review 6.  Changes in brain cholesterol metabolome after excitotoxicity.

Authors:  Wei-Yi Ong; Ji-Hyun Kim; Xin He; Peng Chen; Akhlaq A Farooqui; Andrew M Jenner
Journal:  Mol Neurobiol       Date:  2010-02-06       Impact factor: 5.590

7.  Serum deprivation and re-addition: effects on cyclooxygenase inhibitor sensitivity in cultured glia.

Authors:  James Phillips; Brian Pearce
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

8.  Secretory phospholipase A2 activity in the normal and kainate injected rat brain, and inhibition by a peptide derived from python serum.

Authors:  M-M Thwin; W-Y Ong; C-W Fong; K Sato; K Kodama; A A Farooqui; P Gopalakrishnakone
Journal:  Exp Brain Res       Date:  2003-04-18       Impact factor: 1.972

9.  Characterizing phospholipase A2-induced spinal cord injury-a comparison with contusive spinal cord injury in adult rats.

Authors:  Nai-Kui Liu; William Lee Titsworth; Yi Ping Zhang; Aurela I Xhafa; Christopher B Shields; Xiao-Ming Xu
Journal:  Transl Stroke Res       Date:  2011-12-01       Impact factor: 6.829

Review 10.  When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?

Authors:  Ray Dingledine; Nicholas H Varvel; F Edward Dudek
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.